Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.
Porelio's FOMS adsorbents target PFAS, metals, and genotoxins, outperforming commercial solutions with unmatched selectivity, innovation, and sustainability.
The CHEManager Innovation Pitch is both a showcase and a competition for start-ups in the chemical industry. Each year, industry experts select a winning start-up from the finalists.
Interview with Olli Kähkönen, Nordic Bioproducts Group
Interview with Franziska Walde and Lukas Fischer, Refinq
Interview with Johannes Kabisch (CSO), Joe Heenan (CEO) and Aron Eiermann (CTO), Proteineer
Interview with Sridhar Balaram, Founder and CEO of Flownetics Engineering.
Aralez Bio, a San Francisco-based start-up, has engineered a platform of enzymes that creates 100 times more compound diversity using processes that are also 50 times greener than conventional methods.
The Heidelberg-based start-up Blue Activity replaces 100% of biocides in cooling water treatment with natural, functional microorganisms. The product change increases the efficiency of cooling tower performance and reduces water consumption and operating costs.
Process manufacturing companies waste almost $100 billion globally every year while formulating novel materials and chemicals due to the trial-and-error approach to R&D and the lack of tools to leverage the experimental data in real-time.
Manual experiment monitoring and data capture is still the status quo in most biotech and pharma labs, compromising efficiency and project timescales. But there is a better way.
The Spanish computational chemistry start-up Nextmol (Bytelab Solutions), a spin-off from the Barcelona Supercomputing Centre, offers a software-as-a-service (SaaS) platform that accelerates research and innovation in sustainable specialty chemicals through “in silico” experiments using molecular modeling and artificial intelligence (AI).
The Ghanian start-up Aquamet provides a sustainable and affordable solution to maximize fish farmers´ yield.
In this interview, Christene Smith sits down with Anne Lamp, the CEO & Co-Founder of Traceless Materials, to delve into the groundbreaking world of natural biopolymer materials.
Interview with Alban Chesneau and Nicolas Castet, Carbon Waters
Interview with Florian Hildebrand, Greenlyte Carbon Technologies
Interview with Klara Yoon, Tina Rose and Stephan Enthaler, New Dawn
Interview with Fajer Mushtaq and Silvan Staufert, Oxyle
Interview with Sylke Hassel, previous CEO of PharmaZell and current CEO of Axplora following the merger with Novasep.
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Numerous crises such as climate change, energy shortages, raw material shortages, war in Ukraine and the consequences of the pandemic are putting value chains worldwide to the test.
Interview with Lisa Z. Mobech and Bjol R. Frenkenberger, MIR Insight
CH-Bioforce, based in Raisio, Finland, strives for a cleaner world.
Traditional batch chemistry is too inefficient for a sustainable future. Switching batch processing to continuous processing is inevitable if the world is to reach net zero.
For decades, Ferrate(VI) has been known as the strongest oxidant in the world for the treatment of (industrial) wastewater.
Interest in oligonucleotide therapeutics has grown, as has the market demand, since their emergence as a new drug modality two decades ago.
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
